Cite
HARVARD Citation
Khan, N. et al. (2023). Risk of severe and opportunistic infections and the impact of SARS‐COV‐2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 57 (7), pp. 800-807. [Online].